Get 20% lifetime commission for referring investors to digrin.com
here.
Nkarta, Inc. (NKTX) Financials
NKTX Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| June 30, 2026 | 337.6 million | 89.9 million |
| March 31, 2026 | 372.1 million | 86.2 million |
| Dec. 31, 2025 | 404.2 million | 91.9 million |
| Sept. 30, 2025 | 427.2 million | 89.3 million |
NKTX Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| June 30, 2026 | -24.4 million | 1.9 million |
| March 31, 2026 | -28.6 million | 1.9 million |
| Dec. 31, 2025 | -22.2 million | 1.9 million |
| Sept. 30, 2025 | -18.7 million | 1.8 million |
NKTX Net Income
No data available :(
NKTX Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| June 30, 2026 | 182.8 million | - | 73.5 million |
| March 31, 2026 | 230.4 million | 67.9 million | 7.1 million |
| Dec. 31, 2025 | 276.3 million | - | 76.4 million |
| Sept. 30, 2025 | 282.3 million | - | 76.6 million |
NKTX Shares Outstanding
NKTX Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| June 30, 2026 | 183000 | 29.0 million | 14.1 million | - |
| March 31, 2026 | 413000 | 22.6 million | 5.9 million | - |
| Dec. 31, 2025 | 560000 | 25.3 million | 5.7 million | - |
| Sept. 30, 2025 | 8000 | 20.2 million | 7.1 million | - |
NKTX Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| June 30, 2026 | - | - |
| March 31, 2026 | - | 2.3 million |
| Dec. 31, 2025 | - | 2.3 million |
| Sept. 30, 2025 | - | - |
NKTX
Price: $2.38
52 week price:
Earnings Per Share: -1.59 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 296100
Market Capitalization: 166.9 million